Endocrinology, Vol 136, 598-608, Copyright © 1995 by Endocrine Society

ARTICLES

Glucocorticoids inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decrease beta 1-integrin levels

GA Gronowicz and MB McCarthy
Department of Orthopedics, University of Connecticut Health Center, Farmington 06032.

Prolonged glucocorticoid treatment causes osteoporosis in vivo and inhibits bone formation in vitro. We have previously shown that glucocorticoids inhibit calcification and alter osteoblast organization in a mineralizing bone organ culture system. In this study, the effect of glucocorticoids on osteoblast adhesion to bone matrix proteins and integrin expression was examined in primary rat osteoblasts and a transformed rat osteosarcoma-derived cell line ROS 17/2.8. After 24 h of treatment with corticosterone, these cells displayed a concentration- dependent decrease in adhesion to type I collagen and fibronectin. Adhesion was significantly decreased as early as 4 h after glucocorticoid administration. With 100 nM corticosterone treatment for 24 h, inhibition of the adhesion of ROS 17/2.8 cells and primary osteoblasts to fibronectin was 75 +/- 10% and 50 +/- 8%, and inhibition of adhesion to collagen was 31 +/- 10% and 65 +/- 5%, respectively. This effect was specific for osteoblasts, because glucocorticoids did not change the adhesion of fibroblasts. However, glucocorticoids did inhibit the adhesion of all cell types to rat osteonectin. To determine whether the change in osteoblast attachment to collagen and fibronectin was due to an alteration in integrin levels, the plasma membranes of these cells were labeled with [125I]lactoperoxidase, solubilized, and immunoprecipitated with an antibody to beta 1. A 24-h treatment with 100 nM corticosterone caused 80 +/- 2% and 64 +/- 9% decreases in beta 1 levels in primary osteoblasts and ROS 17/2.8 cells, respectively. These results were confirmed with immunofluorescence microscopy, which showed a glucocorticoid-induced decrease in beta 1 staining. Treatment of primary rat osteoblasts and ROS 17/2.8 cells for 72 h with corticosterone also decreased beta 1-integrin messenger RNA levels in a dose-dependent manner. We have demonstrated that the inhibition of integrin expression by glucocorticoids is involved in the decrease in osteoblast adhesion to bone extracellular matrix proteins. These data suggest that integrin modulation may influence osteoblast function and bone formation and, thus, contribute to glucocorticoid-induced osteoporosis.

This article has been cited by other articles:

				A. E. Kearns, S. Khosla, and P. J. Kostenuik Receptor Activator of Nuclear Factor {kappa}B Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease Endocr. Rev., April 1, 2008; 29(2): 155 - 192. [Abstract] [Full Text] [PDF]

				F.-S. Wang, C.-L. Lin, Y.-J. Chen, C.-J. Wang, K. D. Yang, Y.-T. Huang, Y.-C. Sun, and H.-C. Huang Secreted Frizzled-Related Protein 1 Modulates Glucocorticoid Attenuation of Osteogenic Activities and Bone Mass Endocrinology, May 1, 2005; 146(5): 2415 - 2423. [Abstract] [Full Text] [PDF]

				J. Wang, M. Su, J. Fan, A. Seth, and C. A. McCulloch Transcriptional Regulation of a Contractile Gene by Mechanical Forces Applied through Integrins in Osteoblasts J. Biol. Chem., June 14, 2002; 277(25): 22889 - 22895. [Abstract] [Full Text] [PDF]

				P C Ng, C W K Lam, G W K Wong, C H Lee, P S Cheng, T F Fok, I H S Chan, E Wong, K Cheung, and S Y Lee Changes in markers of bone metabolism during dexamethasone treatment for chronic lung disease in preterm infants Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2002; 86(1): F49 - 54. [Abstract] [Full Text] [PDF]

				R. N. J. de Nijs, J. W. G. Jacobs, J. W. J. Bijlsma, W. F. Lems, R. F. J. M. Laan, H. H. M. Houben, E. J. ter Borg, A. M. Huisman, G. A. W. Bruyn, P. L. M. van Oijen, et al. Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis Rheumatology, December 1, 2001; 40(12): 1375 - 1383. [Abstract] [Full Text] [PDF]

				S. Walsh, G. R. Jordan, C. Jefferiss, K. Stewart, and J. N. Beresford High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis Rheumatology, January 1, 2001; 40(1): 74 - 83. [Abstract] [Full Text] [PDF]

				J. P. Wiebe, D. Muzia, J. Hu, D. Szwajcer, S. A. Hill, and J. L. Seachrist The 4-Pregnene and 5{{alpha}}-Pregnane Progesterone Metabolites Formed in Nontumorous and Tumorous Breast Tissue Have Opposite Effects on Breast Cell Proliferation and Adhesion Cancer Res., February 1, 2000; 60(4): 936 - 943. [Abstract] [Full Text]

				A. Gohel, M.-B. McCarthy, and G. Gronowicz Estrogen Prevents Glucocorticoid-Induced Apoptosis in Osteoblasts in Vivo and in Vitro Endocrinology, November 1, 1999; 140(11): 5339 - 5347. [Abstract] [Full Text]

				D. R. Ganta, M.-B. McCarthy, and G. A. Gronowicz Ascorbic Acid Alters Collagen Integrins in Bone Culture Endocrinology, September 1, 1997; 138(9): 3606 - 3612. [Abstract] [Full Text] [PDF]

				J. D. Graham and C. L. Clarke Physiological Action of Progesterone in Target Tissues Endocr. Rev., August 1, 1997; 18(4): 502 - 519. [Abstract] [Full Text] [PDF]

				A. Moursi, R. Globus, and C. Damsky Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro J. Cell Sci., January 9, 1997; 110(18): 2187 - 2196. [Abstract] [PDF]

				A. Moursi, C. Damsky, J Lull, D Zimmerman, S. Doty, S Aota, and R. Globus Fibronectin regulates calvarial osteoblast differentiation J. Cell Sci., January 6, 1996; 109(6): 1369 - 1380. [Abstract] [PDF]

				C.-F. Lai, X. Feng, R. Nishimura, S. L. Teitelbaum, L. V. Avioli, F. P. Ross, and S.-L. Cheng Transforming Growth Factor-beta Up-regulates the beta 5 Integrin Subunit Expression via Sp1 and Smad Signaling J. Biol. Chem., November 10, 2000; 275(46): 36400 - 36406. [Abstract] [Full Text] [PDF]